Governance
The Human Cell Atlas comprises members from many scientific institutions around the world. It is only by working together that we will be able to achieve the ambitious goals of this project.
The HCA is steered and governed by the HCA Organizing Committee (OC), which is the decision-making body of the HCA. The OC is currently co-chaired by Muzz Haniffa and Chloe Villani, with Holger Heyn and Shyam Prabhakar serving as co-vice-chairs.
Members of the HCA Advisory Committee (AC) provide guidance and insight to the HCA Organizing Committee, and may attend OC meetings as observers.
The OC has an Executive Committee (EC) that is responsible for performing routine tasks between OC meetings, reviewing meeting agendas, and providing guidance to the HCA Executive Office.
Committee Members
University of Buenos Aires, Argentina
University of Toronto, Canada
CeMM, Austria
Fondazione Human Technopole, Italy & RIKEN, Japan
Berlin Institute of Health – Charité Universitätsmedizin Berlin, Germany
Wellcome Sanger Institute/Newcastle University, UK
CNAG, Spain
Stanford University, USA
Michigan University, USA
University of California, San Francisco, USA
Allen Institute, USA
John C. Martin Centre for Liver Research & Innovations and Liver Foundation, West Bengal, India
Radboud University, The Netherlands
Stanford University, USA
RIKEN and University of Tokyo, Japan
Memorial Sloan Kettering Cancer Institute, USA
Genome Institute of Singapore, Singapore
Genentech, USA
Albert Einstein Research and Education Institute, Brazil
Genomic Institute of Singapore, A*STAR, Singapore
Fondazione Human Technopole, Italy
Cambridge Stem Cell Institute & Dept Medicine, Cambridge University, UK
Helmholtz-Munich, Germany
Massachusetts General Hospital, Harvard Medical School and Broad Institute, USA
University of Melbourne, Australia
Alumni (OC)
Weizmann Institute of Science, Israel
Peter Campbell
2017-2019
Wellcome Sanger Institute, UK
Hans Clevers
2017-2025
Hubrecht Institute, The Netherlands
Broad Institute, USA
McGill University, Canada
Eric Lander
2017-2021
Broad Institute, USA
Genentech, USA; EMBL-EBI, Cambridge, UK
Mount Sinai, USA
Walter + Eliza Hall Institute of Medical Research, Australia
Chris Ponting
2017-2019
Edinburgh University, UK
Steve Quake
2017-2022
Stanford University / CZ Biohub, USA
Helmholtz Association, Germany
Ehud Shapiro
2017-2019
Weizmann Institute, Israel
Michael Stratton
2017-2022
Wellcome Sanger Institute, UK
Prinses Maxima Centrum, The Netherlands
Massachusetts Institute of Technology, USA
Caltech, USA
Howard Hughes Medical Institute, USA and Harvard University, USA
Hubrecht Institute, The Netherlands
Organising Committee (OC)
Broad Institute, USA
Karolinska Institutet, Sweden
Genentech, USA; EMBL-EBI, Cambridge, UK
Mount Sinai, USA
Helmholtz Association, Germany
Prinses Maxima Centrum, The Netherlands
Massachusetts Institute of Technology, USA
Howard Hughes Medical Institute, USA and Harvard University, USA
Hubrecht Institute, The Netherlands
Advisory Committee (AC)
University of Toronto, Canada
Fondazione Human Technopole, Italy & RIKEN, Japan
Wellcome Sanger Institute/Newcastle University, UK
Genome Institute of Singapore, Singapore
Genentech, USA
Cambridge Stem Cell Institute & Dept Medicine, Cambridge University, UK
Massachusetts General Hospital, Harvard Medical School and Broad Institute, USA